Home › Funds › Vanguard Group › APLS

Vanguard Group position in APLS

APELLIS PHARMACEUTICALS INC

Latest position (Q4 2025)10.67M sh
Reported value held$268.15M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q1 2021 6.10M $261.94M New
Q2 2021 6.34M $400.97M Add
Q3 2021 6.75M $222.56M Add
Q4 2021 7.92M $374.32M Add
Q1 2022 8.57M $435.40M Add
Q2 2022 8.73M $394.62M Add
Q3 2022 9.03M $616.82M Add
Q4 2022 9.21M $476.38M Add
Q1 2023 9.53M $628.53M Add
Q2 2023 9.40M $856.46M Reduce
Q3 2023 9.47M $360.24M Add
Q4 2023 9.56M $572.00M Add
Q1 2024 9.51M $558.75M Reduce
Q2 2024 9.81M $376.29M Add
Q3 2024 9.82M $283.08M Hold
Q4 2024 10.05M $320.57M Add
Q1 2025 10.13M $221.55M Add
Q2 2025 10.15M $175.78M Hold
Q3 2025 9.99M $226.01M Reduce
Q4 2025 10.67M $268.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding APLS

All APLS fund holders →